Drug Shortage Report for NAT-RIZATRIPTAN ODT
Report ID | 67512 |
Drug Identification Number | 02436604 |
Brand name | NAT-RIZATRIPTAN ODT |
Common or Proper name | Rizatriptan Benzoate |
Company Name | NATCO PHARMA (CANADA) INC |
Market Status | MARKETED |
Active Ingredient(s) | RIZATRIPTAN |
Strength(s) | 5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 6 |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-01-01 |
Actual start date | |
Estimated end date | 2019-02-06 |
Actual end date | 2019-02-06 |
Shortage status | Resolved |
Updated date | 2019-02-07 |
Company comments | Available product is short-dated. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-11-23 | English | Compare |
v2 | 2018-11-23 | French | Compare |
v3 | 2019-01-11 | English | Compare |
v4 | 2019-01-23 | English | Compare |
v5 | 2019-02-04 | English | Compare |
v6 | 2019-02-04 | French | Compare |
v7 | 2019-02-05 | English | Compare |
v8 | 2019-02-05 | French | Compare |
v9 | 2019-02-07 | French | Compare |
Showing 1 to 9 of 9